| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
American Journal of Clinical Nutrition, Vol 68, 1453S-1461S, Copyright © 1998 by The American Society for Clinical Nutrition, Inc
REVIEW ARTICLES |
KD Setchell, L Zimmer-Nechemias, J Cai and JE Heubi
Clinical Mass Spectrometry Center, Children's Hospital Medical Center, Cincinnati, OH 45229, USA. setck0@chmcc.org
Soy-based infant formulas have been in use for >30 y. These formulas are manufactured from soy protein isolates and contain significant amounts of phytoestrogens of the isoflavone class. As determined by HPLC, the isoflavone compositions of commercially available formulas are similar qualitatively and quantitatively and are consistent with the isoflavone composition of soy protein isolates. Genistein, found predominantly in the form of glycosidic conjugates, accounts for >65% of the isoflavones in soy-based formulas. Total isoflavone concentrations of soy-based formulas prepared for infant feeding range from 32 to 47 mg/L, whereas isoflavone concentrations in human breast milk are only 5.6 +/- 4.4 microg/L (mean +/- SD, n = 9). Infants fed soy-based formulas are therefore exposed to 22-45 mg isoflavones/d (6- 11 mg x kg body wt(-1) x d(-1)), whereas the intake of these phytoestrogens from human milk is negligible (<0.01 mg/d). The metabolic fate of isoflavones from soy-based infant formula is described. Plasma isoflavone concentrations reported previously for 4- mo-old infants fed soy-based formula were 654-1775 microg/L (mean: 979.7 microg/L: Lancet 1997:350;23-7), significantly higher than plasma concentrations of infants fed either cow-milk formula (mean +/- SD: 9.4 +/- 1.2 microg/L) or human breast milk (4.7 +/- 1.3 microg/L). The high steady state plasma concentration of isoflavones in infants fed soy- based formula is explained by reduced intestinal biotransformation, as evidenced by low or undetectable concentrations of equol and other metabolites, and is maintained by constant daily exposure from frequent feeding. Isoflavones circulate at concentrations that are 13,000-22,000- fold higher than plasma estradiol concentrations in early life. Exposure to these phytoestrogens early in life may have long-term health benefits for hormone-dependent diseases.
This article has been cited by other articles:
|
|
 |
|
  C. W. Xiao Health Effects of Soy Protein and Isoflavones in Humans J. Nutr., June 1, 2008; 138(6): 1244S - 1249S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Montani, M. Penza, M. Jeremic, G. Biasiotto, G. La Sala, M. De Felici, P. Ciana, A. Maggi, and D. Di Lorenzo Genistein is an Efficient Estrogen in the Whole-Body throughout Mouse Development Toxicol. Sci., May 1, 2008; 103(1): 57 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Mardon, J. Mathey, S. Kati-Coulibaly, C. Puel, M.-J. Davicco, P. Lebecque, M.-N. Horcajada, and V. Coxam Influence of Lifelong Soy Isoflavones Consumption on Bone Mass in the Rat Experimental Biology and Medicine, February 1, 2008; 233(2): 229 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Andres, S. M. Donovan, T. B. Kuhlenschmidt, and M. S. Kuhlenschmidt Isoflavones at Concentrations Present in Soy Infant Formula Inhibit Rotavirus Infection in Vitro J. Nutr., September 1, 2007; 137(9): 2068 - 2073. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A Franke, B. M Halm, L. J Custer, Y. Tatsumura, and S. Hebshi Isoflavones in breastfed infants after mothers consume soy. Am. J. Clinical Nutrition, August 1, 2006; 84(2): 406 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A.L. Tan, M. Walker, K. Morris, I. Greig, J. I. Mason, and R. M. Sharpe Infant feeding with soy formula milk: effects on puberty progression, reproductive function and testicular cell numbers in marmoset monkeys in adulthood Hum. Reprod., April 1, 2006; 21(4): 896 - 904. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. V. Soucy, H. D. Parkinson, M. A. Sochaski, and S. J. Borghoff Kinetics of Genistein and Its Conjugated Metabolites in Pregnant Sprague-Dawley Rats Following Single and Repeated Genistein Administration Toxicol. Sci., March 1, 2006; 90(1): 230 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Jefferson, R. Newbold, E. Padilla-Banks, and M. Pepling Neonatal Genistein Treatment Alters Ovarian Differentiation in the Mouse: Inhibition of Oocyte Nest Breakdown and Increased Oocyte Survival Biol Reprod, January 1, 2006; 74(1): 161 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. N. Jefferson, E. Padilla-Banks, and R. R. Newbold Adverse Effects on Female Development and Reproduction in CD-1 Mice Following Neonatal Exposure to the Phytoestrogen Genistein at Environmentally Relevant Doses Biol Reprod, October 1, 2005; 73(4): 798 - 806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. Setchell, C. Clerici, E. D Lephart, S. J Cole, C. Heenan, D. Castellani, B. E Wolfe, L. Nechemias-Zimmer, N. M Brown, T. D Lund, et al. S-Equol, a potent ligand for estrogen receptor {beta}, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora Am. J. Clinical Nutrition, May 1, 2005; 81(5): 1072 - 1079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-C. Chen and S. M. Donovan Genistein at a Concentration Present in Soy Infant Formula Inhibits Caco-2BBe Cell Proliferation by Causing G2/M Cell Cycle Arrest J. Nutr., June 1, 2004; 134(6): 1303 - 1308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Maubach, H. T. Depypere, J. Goeman, J. Van Der Eycken, A. Heyerick, M. E. Bracke, P. Blondeel, and D. De Keukeleire Distribution of Soy-Derived Phytoestrogens in Human Breast Tissue and Biological Fluids Obstet. Gynecol., May 1, 2004; 103(5): 892 - 898. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Merritt and B. H. Jenks Safety of Soy-Based Infant Formulas Containing Isoflavones: The Clinical Evidence J. Nutr., May 1, 2004; 134(5): 1220S - 1224S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. A. Greim The Endocrine and Reproductive System: Adverse Effects of Hormonally Active Substances? Pediatrics, April 1, 2004; 113(4/S1): 1070 - 1075. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. R. Setchell, N. M. Brown, P. B. Desai, L. Zimmer-Nechimias, B. Wolfe, A. S. Jakate, V. Creutzinger, and J. E. Heubi Bioavailability, Disposition, and Dose-Response Effects of Soy Isoflavones When Consumed by Healthy Women at Physiologically Typical Dietary Intakes J. Nutr., April 1, 2003; 133(4): 1027 - 1035. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. R. Setchell, N. M. Brown, and E. Lydeking-Olsen The Clinical Importance of the Metabolite Equol--A Clue to the Effectiveness of Soy and Its Isoflavones J. Nutr., December 1, 2002; 132(12): 3577 - 3584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. N. Jefferson, J. F. Couse, E. Padilla-Banks, K. S. Korach, and R. R. Newbold Neonatal Exposure to Genistein Induces Estrogen Receptor (ER){alpha} Expression and Multioocyte Follicles in the Maturing Mouse Ovary: Evidence for ER{beta}-Mediated and Nonestrogenic Actions Biol Reprod, October 1, 2002; 67(4): 1285 - 1296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. Setchell, N. M Brown, L. Zimmer-Nechemias, W. T Brashear, B. E Wolfe, A. S Kirschner, and J. E Heubi Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability Am. J. Clinical Nutrition, August 1, 2002; 76(2): 447 - 453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Mendez, M. S. Anthony, and L. Arab Soy-Based Formulae and Infant Growth and Development: A Review J. Nutr., August 1, 2002; 132(8): 2127 - 2130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Sharpe, B. Martin, K. Morris, I. Greig, C. McKinnell, A. S. McNeilly, and M. Walker Infant feeding with soy formula milk: effects on the testis and on blood testosterone levels in marmoset monkeys during the period of neonatal testicular activity Hum. Reprod., July 1, 2002; 17(7): 1692 - 1703. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yellayi, A. Naaz, M. A. Szewczykowski, T. Sato, J. A. Woods, J. Chang, M. Segre, C. D. Allred, W. G. Helferich, and P. S. Cooke The phytoestrogen genistein induces thymic and immune changes: A human health concern? PNAS, May 28, 2002; 99(11): 7616 - 7621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Csaba and A Inczefi-Gonda Effect of a single treatment (imprinting) with genistein or combined treatment with genistein+benzpyrene on the binding capacity of glucocorticoid and estrogen receptors of adult rats Human and Experimental Toxicology, May 1, 2002; 21(5): 231 - 234. [Abstract] [PDF]
|
|
|
|
|
|
L. You, M. Casanova, E. J. Bartolucci, M. W. Fryczynski, D. C. Dorman, J. I. Everitt, K. W. Gaido, S. M. Ross, and H. d'A. Heck Combined Effects of Dietary Phytoestrogen and Synthetic Endocrine-Active Compound on Reproductive Development in Sprague-Dawley Rats: Genistein and Methoxychlor Toxicol. Sci., March 1, 2002; 66(1): 91 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Badger, M. J. J. Ronis, R. Hakkak, J. C. Rowlands, and S. Korourian The Health Consequences of Early Soy Consumption J. Nutr., March 1, 2002; 132(3): 559S - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Belcher and A. Zsarnovszky Estrogenic Actions in the Brain: Estrogen, Phytoestrogens, and Rapid Intracellular Signaling Mechanisms J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 408 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Newbold, E. P. Banks, B. Bullock, and W. N. Jefferson Uterine Adenocarcinoma in Mice Treated Neonatally with Genistein Cancer Res., June 1, 2001; 61(11): 4325 - 4328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Andlauer, J. Kolb, and P. Furst Isoflavones from Tofu Are Absorbed and Metabolized in the Isolated Rat Small Intestine J. Nutr., December 1, 2000; 130(12): 3021 - 3027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Flynn, S. A. Ferguson, K. B. Delclos, and R. R. Newbold Effects of Genistein Exposure on Sexually Dimorphic Behaviors in Rats Toxicol. Sci., June 1, 2000; 55(2): 311 - 319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. R. Setchell and A. Cassidy Dietary Isoflavones: Biological Effects and Relevance to Human Health J. Nutr., March 1, 1999; 129(3): 758 - 758. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
